/TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals

NEWS

TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals

PRNewswire

2025/06/23

TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals News provided by TuHURA Biosciences, Inc. Jun 23, 2025, 17:00 ET Share this article Share to X Share this article Share to X (PRNewsfoto/Kintara Therapeutics) Kineta Logo

Summary

/PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immune-oncology company developing novel technologies to overcome...